Aperio to Present at 29th Annual J.P. Morgan Healthcare Conference

Digital Pathology Leader to Discuss Rapidly Emerging Healthcare IT/Diagnostics Market

VISTA, Calif.--(BUSINESS WIRE)-- Aperio, the global leader in providing digital pathology solutions that improve patient care, today announced that Dirk G. Soenksen, chief executive officer, will speak at the J.P. Morgan 29th Annual Healthcare Conference on January 11, 2011, at the Westin St. Francis Hotel in San Francisco. The Aperio presentation is scheduled to begin at 1:30 pm Pacific Standard Time.

During his session, Mr. Soenksen will provide an overview of the multi-billion dollar digital pathology market and discuss the strategic value of digital pathology in personalized medicine and molecular diagnostics. He will also describe Aperio’s success in increasing adoption in hospitals by enabling pathologists and other physicians to improve patient care.

Aperio is the recognized leader in digital pathology, with a rapidly growing global installed base of more than 750 systems in over 30 countries, including nearly 500 systems in hospitals and references labs, the 13 largest pharmaceutical companies and a multitude of biotechnology and government organizations.

About J.P. Morgan Healthcare Conference

The J.P. Morgan event is the premier conference of its kind, bringing together established industry leaders, emerging fast-growth companies, innovative technology creators and globally minded service providers. In 2011, the organizers expect more than 300 companies, both public and private, to deliver presentations to more than 4,000 investors.

About Aperio

Aperio is the leading provider of digital pathology solutions in hospitals, reference labs, and pharmaceutical and research institutions across the world. Today, our affordable and complete product portfolio improves patient care by enhancing quality assurance, delivering more efficient workflows, facilitating access to new and more targeted therapies, and improving pathologists’ skills via lifelong education. Our comprehensive product line features our ScanScope® scanners, Spectrum™ image management (PACS) software, SecondSlide® slide sharing service for pathology, and image analysis tools and services. Aperio’s products are FDA cleared for specific clinical applications, and are intended for research and education use for other applications. For clearance updates and more information please visit www.aperio.com.



CONTACT:

Aperio
Jessica Witkowski, 760-539-1162
Director, Marketing Communications
[email protected]
or
Myla Wagner Public Relations
Myla Wagner, 925-736-7515
[email protected]

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:   Health  Biotechnology  Hospitals  Medical Devices  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.